SooYoung Lee, Ph.D. has returned to Goodwin Biotechnology as chief operating officer. Dr. Lee will report to the newly appointed chief executive officer, Karl Pinto, and will oversee all aspects of Goodwin’s contract manufacturing operations. He previously served at Goodwin as senior vice president, operations from 2010 to 2011. Dr. Lee has had a multi-decade career in the biological industry. He has held several leadership positions at such biopharma companies and CMOs as SAIC – Frederic...